U.S., March 5 -- An application to own the trademark for 'DEL-BRAX' has been filed on Jun. 25, 2024.
Owner(s):
Avidity Biosciences, Inc.; 10578 Science Drive, Suite 125, , California
Goods and/or Services:
For: Oligonucleotide-conjugate based therapies, oligonucleotide-antibody conjugate based therapies, and oligonucleotide-antibody fragment conjugate based therapies for the treatment of metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, neuromuscular, rare muscle diseases, cardiomyopathies, heart muscle diseases, muscular dystrophies, muscle atrophy, genitourinary, oncological, hepatological, ophthalmic, respiratory, central and/or peripheral neurological, gastrointestinal, hormonal, dermatological, psychiatric and...